PUBLISHER: TechNavio | PRODUCT CODE: 1788475
PUBLISHER: TechNavio | PRODUCT CODE: 1788475
The generative AI in personalized medicine market is forecasted to grow by USD 8,455.6 mn during 2024-2029, accelerating at a CAGR of 41.1% during the forecast period. The report on the generative AI in personalized medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by accelerated drug discovery and development cycles as a primary catalyst, intensifying strategic collaborations and influx of capital as a key market accelerator, and expansion of accessible multimodal data and computational power as a foundational enabler.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 36.6% |
CAGR | 41.1% |
Incremental Value | $8,455.6 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's generative AI in personalized medicine market is segmented as below:
By Application
By End-user
By Therapeutic Area
By Geographical Landscape
This study identifies the rise of biological foundation models and AI factories as one of the prime reasons driving the generative AI in personalized medicine market growth during the next few years. Also, emergence of multimodal AI for a holistic view of disease and paradigm shift toward in-silico clinical trials and digital twins will lead to sizable demand in the market.
The report on the generative AI in personalized medicine market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generative AI in personalized medicine market vendors that include Ardigen S.A., BenevolentAI, Freenome Holdings Inc., Google LLC, Insilico Medicine, International Business Machines Corp., Mediwhale Inc., Microsoft Corp., NVIDIA Corp., Owkin Inc., PathAI Inc., Qure.ai Technologies Pvt. Ltd., Shenzhen Jingtai Technology Co. Ltd., Syntekabio Inc., Tempus Labs Inc., and TurinTech AI Inc.. Also, the generative AI in personalized medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: